LETTER TO EDITOR
Year : 2011  |  Volume : 43  |  Issue : 1  |  Page : 91

Anomalies in alloxan-induced diabetic model: It is better to standardize it first

Dinesh K Jain, Raj Kumar Arya
Department of Pharmacology, G.R. Medical College, Gwalior, Madhya Pradesh - 474 001, India

Correspondence Address:
Dinesh K Jain
Department of Pharmacology, G.R. Medical College, Gwalior, Madhya Pradesh - 474 001
India

Source of Support: None, Conflict of Interest: None

Check

9

DOI: 10.4103/0253-7613.75684

1. Alloxan is very rapidly destroyed in the body. Its half-life is less than 1 minute. Hence, its action is most unpredictable unless it is administered by rapid intravenous injection. Slow rate of intravenous injection reduces the efficacy of the agent. ^[1] But in alloxan-induced models, researchers usually use intraperitoneal or other routes, which makes it less capable to induce diabetes of such duration as required for study. During intraperitoneal, intramuscular and subcutaneous routes of administration, onset of alloxan action would be delayed. Will it not be sufficient to destroy alloxan in body? Will delayed onset of action not make it less efficient in producing diabetes in animals?
2. Very young animals have a high resistance to the diabetogenic effect of alloxan. ^[2]
3. Damage to the renal tubules by alloxan also alters blood glucose level which may also influence the results of study.
4. The susceptibility to both toxic and diabetogenic doses varies widely not only in different species but also among animals of the same species. ^[1]
5. Rats were more sensitive to a constant dose of alloxan after a fore period on a high fat diet and less sensitive after a high carbohydrate and protein diet. ^[3]
6. The spontaneous recovery is particularly evident in rats and mice, in which the majority of animals become normoglycemic. The recovery from the diabetes is believed to be the consequence of either a multiplication of β cells from the duct epithelium or the exocrine portion of the pancreas. ^[4] This is the reason why mild diabetes produced by alloxan recovers spontaneously in rats.
7. Lower doses of alloxan (90-140 mg/kg, i.p.) can result in auto-reversion to normal state. It has been found that in many research studies, the dose of alloxan used to induce diabetes was suboptimal. In these studies, it was found that alloxan induces very mild diabetes. However, in these animals, revert back to the blood glucose values reverted back to normal in a week.
8. β cells of islet of Langerhans in rats show regenerative capacity. ^[5] Thus, the illusion of antidiabetic effect of experimental product is produced.
9. Production of diabetes also depends upon the speed of the intravenous injections at a given dose level, the slower injection rates causing less effect. ^[6]
10. Human islet tissue is exceedingly resistant to the degenerative effects of alloxan. Alloxan diabetes differs strikingly from other types of experimental diabetes in the course and nature of the lesions which are developed. As yet, there is no evidence that alloxan-induced diabetes mellitus is related to human diabetes mellitus. ^[7]

» References

1.	Goodman ls, Gilman A. The Pharmacological Basis of Therapeutics. 2 nd ed. New York: Macmilan Company; 1955. p. 1636-8.
2.	Rerup CC. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 1970;22:485-518.
3.	Bunnag SC, Warner NE, Bunnag S. Effect of alloxan on the mouse pancreas during and after recovery from diabetes. Diabetes 1967;16:83-9.
4.	Lazarow A. Spontaneous recovery from alloxan diabetes in the rat. Diabetes 1952;1:363-72.
5.	Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β cells are formed by self-duplication rather than stem cell differentiation. Nature 2004;429:41-6.
6.	Pincus IJ, Hurwitz JJ, Scott ME. Effect of rate of injection of alloxan on development of diabetes in rabbits. Proc Soc Exp Biol Med 1954;86:553-4.
7.	Leukens FD. Alloxan diabetes. Physiol Rev 1948;28:318-26.

This article has been cited by 1 Self-recovery in diabetic Sprague Dawley rats induced by intraperitoneal alloxan and streptozotocin Indah Fajarwati, Dedy Duryadi Solihin, Tutik Wresdiyati, Irmanida Batubara Heliyon. 2023; : e15533 [Pubmed] | [DOI] 2 Rodent Models of Diabetic Retinopathy as a Useful Research Tool to Study Neurovascular Cross-Talk Karolina Polewik, Maciej Kosek, Daniel Jamrozik, Iwona Matuszek, Adrian Smedowski, Joanna Lewin-Kowalik, Marita Pietrucha-Dutczak Biology. 2023; 12(2): 262 [Pubmed] | [DOI] 3 ?Antidiabetic activity of Anredera cordifolia (Ten.) Stennis extracts with different ethanol percentages: an evaluation based on in vitro, in vivo, and molecular studies Asri Sulfianti, Nisrina Firdausi, Nurhadi Nurhadi, Ngatinem Ngatinem, Kurnia Agustini, Sri Ningsih Pharmacia. 2023; 70(1): 39 [Pubmed] | [DOI] 4 Evaluating Cytochrome P-2E1 Induction in Diabetic Rats and Rabbits Asieh Karimani Journal of Medical Sciences. 2022; 22(4): 158 [Pubmed] | [DOI] 5 Cognitive impairments in type 1 diabetes mellitus model mice are associated with synaptic protein disorders Yiming Wang, Yueqi Yang, Yiqiong Liu, Angyang Guo, Yan Zhang Neuroscience Letters. 2022; 777: 136587 [Pubmed] | [DOI] 6 The effect of arbutin and aerobic training on plasma leptin and adiponectin concentrations in alloxan-induced diabetic rats Niloufar Eskandari Goodarzi, Hoseyn Fatolahi, Saleh Rahmati Ahmadabad, Mehdi Pouramir, Shiva Mohammadi, Zohreh Khojasteh, Mobina Aghajani, Mohammad Ali Azarbayjani Nutrition Clinique et Métabolisme. 2022; [Pubmed] | [DOI] 7 Botanical description, bioactivity guided isolation and in silico mode of action of anti-diabetic constituents of Pterocarpus dalbergioides flowers Shaimaa R. Ahmed, Moshera M. El-sherei, Camilia G. Michel, Arafa Musa, Mohammad M. Al-Sanea, Sumera Qasim South African Journal of Botany. 2022; 147: 163 [Pubmed] | [DOI] 8 High-fat diet-induced nonalcoholic steatohepatitis is accelerated by low carnitine and impaired glucose tolerance in novel murine models Yui Terayama, Shin-ichi Nakamura, Kazuyuki Mekada, Tetsuro Matsuura, Kiyokazu Ozaki Laboratory Investigation. 2022; [Pubmed] | [DOI] 9 Polyherbal mixture ameliorates hyperglycemia, hyperlipidemia and histopathological changes of pancreas, kidney and liver in a rat model of type 1 diabetes Višnja Madic, Aleksandra Petrovic, Marina Juškovic, Dragana Jugovic, Ljubiša Djordjevic, Gordana Stojanovic, Perica Vasiljevic Journal of Ethnopharmacology. 2021; 265: 113210 [Pubmed] | [DOI] 10 Biomedical Properties of Propolis on Diverse Chronic Diseases and Its Potential Applications and Health Benefits Nelly Rivera-Yañez, C. Rebeca Rivera-Yañez, Glustein Pozo-Molina, Claudia F. Méndez-Catalá, Adolfo R. Méndez-Cruz, Oscar Nieto-Yañez Nutrients. 2020; 13(1): 78 [Pubmed] | [DOI]